Skyline Venture Partners Qualified Purchaser Fund IV L P

CIK 00013246176 companiesPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001324617

Recent Transactions

50 trades

Conversion
Protara Therapeutics, Inc.$TARA
Series C Convertible Preferred Stock
2014-10-27−2,436,437→ 0 total
Other
Protara Therapeutics, Inc.$TARA
Option (Right to Purchase)
2014-10-27−1,389,064→ 0 total
Conversion
Protara Therapeutics, Inc.$TARA
Series A Convertible Preferred Stock
2014-10-27−5,000,000→ 0 total
Exercise of In-Money
Protara Therapeutics, Inc.$TARA
Common Stock
2014-10-27$4.60/sh+121,760→ 1,488,968 total
Conversion
Protara Therapeutics, Inc.$TARA
Series A-1 Convertible Preferred Stock
2014-10-27−2,341,664→ 0 total
Purchase
Protara Therapeutics, Inc.$TARA
Common Stock
2014-10-27$10.00/sh+200,000→ 200,000 total
Conversion
Protara Therapeutics, Inc.$TARA
Common Stock
2014-10-27+1,167,208→ 1,367,208 total
Conversion
Protara Therapeutics, Inc.$TARA
Series D Convertible Preferred Stock
2014-10-27−3,932,747→ 0 total
Exercise of In-Money
Protara Therapeutics, Inc.$TARA
Warrants (Right to Buy)
2014-10-27−121,760→ 0 total
Sale
Protara Therapeutics, Inc.$TARA
Common Stock
2014-10-27$10.00/sh−56,038→ 1,432,930 total
Conversion
Protara Therapeutics, Inc.$TARA
Series B Convertible Preferred Stock
2014-10-27−2,173,913→ 0 total
Other
TETRAPHASE PHARMACEUTICALS INC
Common Stock
2014-03-12+4,493→ 4,493 total
Other
TETRAPHASE PHARMACEUTICALS INC
Common Stock
2014-03-12−300,000→ 1,890,146 total
Other
TALPHERA, INC.$TLPH
Common Stock
2014-03-07−1,300,000→ 2,871,933 total
Conversion
CONCERT PHARMACEUTICALS, INC.
Common Stock
2014-02-20+530,974→ 952,726 total
Conversion
CONCERT PHARMACEUTICALS, INC.
Common Stock
2014-02-20+106,194→ 1,058,920 total
Purchase
CONCERT PHARMACEUTICALS, INC.
Common Stock
2014-02-20$14.00/sh+150,000→ 1,208,920 total
Conversion
CONCERT PHARMACEUTICALS, INC.
Series A Convertible Preferred Stock
2014-02-20−2,200,000→ 0 total
Conversion
CONCERT PHARMACEUTICALS, INC.
Common Stock
2014-02-20+389,380→ 421,752 total
Conversion
CONCERT PHARMACEUTICALS, INC.
Series C Convertible Preferred Stock
2014-02-20−600,000→ 0 total
Conversion
CONCERT PHARMACEUTICALS, INC.
Series B Convertible Preferred Stock
2014-02-20−3,000,000→ 0 total
Conversion
TETRAPHASE PHARMACEUTICALS INC
Series C Convertible Participating Preferred Stock
2013-03-25−27,226,760→ 0 total
Conversion
TETRAPHASE PHARMACEUTICALS INC
Common Stock
2013-03-25+94,003→ 176,417 total
Conversion
TETRAPHASE PHARMACEUTICALS INC
Common Stock
2013-03-25+938,853→ 1,509,133 total
Conversion
TETRAPHASE PHARMACEUTICALS INC
Series B Convertible Participating Preferred Stock
2013-03-25−11,422,045→ 0 total
Conversion
TETRAPHASE PHARMACEUTICALS INC
Common Stock
2013-03-25+72,069→ 82,414 total
Conversion
TETRAPHASE PHARMACEUTICALS INC
Common Stock
2013-03-25+393,863→ 570,280 total
Conversion
TETRAPHASE PHARMACEUTICALS INC
Series A-1 Convertible Participating Preferred Stock
2013-03-25−2,090,000→ 0 total
Purchase
TETRAPHASE PHARMACEUTICALS INC
Common Stock
2013-03-25$7.00/sh+681,012→ 2,190,145 total
Conversion
TETRAPHASE PHARMACEUTICALS INC
Series A-2 Convertible Participating Preferred Stock
2013-03-25−2,726,086→ 0 total
Purchase
TALPHERA, INC.$TLPH
Common Stock
2012-05-29$3.40/sh+284,698→ 4,161,933 total
Purchase
TALPHERA, INC.$TLPH
Warrant to purchase Common Stock
2012-05-29$0.13/sh+256,228→ 256,228 total
Conversion
TALPHERA, INC.$TLPH
Common Stock
2011-02-16+915,798→ 2,067,366 total
Conversion
TALPHERA, INC.$TLPH
Common Stock
2011-02-16+29,241→ 2,651,292 total
Conversion
TALPHERA, INC.$TLPH
Series A Convertible Preferred Stock
2011-02-16−500,000→ 0 total
Conversion
TALPHERA, INC.$TLPH
Series C Convertible Preferred Stock
2011-02-16−26,511→ 0 total
Exercise of In-Money
TALPHERA, INC.$TLPH
Warrant to purchase Series C Convertible Preferred Stock
2011-02-16−12,914→ 0 total
Exercise of In-Money
TALPHERA, INC.$TLPH
Series C Convertible Preferred Stock
2011-02-16+12,914→ 12,914 total
Conversion
TALPHERA, INC.$TLPH
Series C Convertible Preferred Stock
2011-02-16−2,730→ 0 total
Conversion
TALPHERA, INC.$TLPH
Common Stock
2011-02-16+468,664→ 1,151,568 total
Conversion
TALPHERA, INC.$TLPH
Common Stock
2011-02-16+554,685→ 2,622,051 total
Conversion
TALPHERA, INC.$TLPH
Series B Convertible Preferred Stock
2011-02-16−312,500→ 0 total
Exercise of In-Money
TALPHERA, INC.$TLPH
Series C Convertible Preferred Stock
2011-02-16+125,386→ 125,386 total
Other
TALPHERA, INC.$TLPH
Warrant to purchase Series C Convertible Preferred Stock
2011-02-16+12,914→ 12,914 total
Purchase
TALPHERA, INC.$TLPH
Common Stock
2011-02-16$5.00/sh+1,235,943→ 3,877,235 total
Conversion
TALPHERA, INC.$TLPH
Series C Convertible Preferred Stock
2011-02-16−915,798→ 0 total
Conversion
TALPHERA, INC.$TLPH
Convertible Promissory Note
2011-02-16→ 0 total
Exercise of In-Money
TALPHERA, INC.$TLPH
Warrant to purchase Series C Convertible Preferred Stock
2011-02-16−125,386→ 0 total
Sale
TALPHERA, INC.$TLPH
Series C Convertible Preferred Stock
2011-02-16−98,875→ 26,511 total
Sale
TALPHERA, INC.$TLPH
Series C Convertible Preferred Stock
2011-02-16−10,184→ 2,730 total

Companies

Recent Filings

Address

525 UNIVERSITY AVE.

PALO ALTO, CA, 94301

View on SEC.gov